GAM
JAZZ icon

Guinness Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Guinness Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Sell
2,483
-305
-11% -$53.3K 0.01% 92
2025
Q4 		$475K Sell
2,788
-512
-16% -$78.5K 0.01% 94
2025
Q3 		$426K Buy
+3,300
New +$396K 0.01% 93

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Guinness Asset Management's JAZZ Position: Q1 2026 in Review

Guinness Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, selling an estimated $53.3K and leaving 2,483 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #92.

Guinness Asset Management first reported a position in JAZZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $475K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Guinness Asset Management held 2,483 shares of Jazz Pharmaceuticals worth $469K as of Q1 2026.
  • Guinness Asset Management sold 305 Jazz Pharmaceuticals shares in Q1 2026, an estimated $53.3K.
  • Jazz Pharmaceuticals made up 0.01% of Guinness Asset Management's portfolio in Q1 2026, its #92 holding.
  • Guinness Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Guinness Asset Management's Jazz Pharmaceuticals position peaked at $475K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Guinness Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.